Abstract:Pax-6 is an evolutionarily conserved transcription factor regulating brain and eye development. Four Pax-6 isoforms have been reported previously. Although the longer Pax-6 isoforms (p46 and p48) bear two DNA-binding domains, the paired domain (PD) and the homeodomain (HD), the shorter Pax-6 isoform p32 contains only the HD for DNA binding. Although a third domain, the proline-, serine and threonine-enriched activation (PST) domain, in the C termini of all Pax-6 isoforms mediates their transcriptional modulation via phosphorylation, how p32 Pax-6 could regulate target genes remains to be elucidated. In the present study, we show that sumoylation at K91 is required for p32 Pax-6 to bind to a HD-specific site and regulate expression of target genes. First, in vitro-synthesized p32 Pax-6 alone cannot bind the P3 sequence, which contains the HD recognition site, unless it is preincubated with nuclear extracts precleared by anti-Pax-6 but not by anti-small ubiquitin-related modifier 1 (anti-SUMO1) antibody. Second, in vitro-synthesized p32 Pax-6 can be sumoylated by SUMO1, and the sumoylated p32 Pax-6 then can bind to the P3 sequence. Third, Pax-6 and SUMO1 are colocalized in the embryonic optic and lens vesicles and can be coimmunoprecipitated. Finally, SUMO1-conjugated p32 Pax-6 exists in both the nucleus and cytoplasm, and sumoylation significantly enhances the DNA-binding ability of p32 Pax-6 and positively regulates gene expression. Together, our results demonstrate that sumoylation activates p32 Pax-6 in both DNA-binding and transcriptional activities. In addition, our studies demonstrate that p32 and p46 Pax-6 possess differential DNA-binding and regulatory activities.

Differential Regulation of C-Jun-dependent Transcription by SUMO-specific Proteases.

Sumoylation Activates The Transcriptional Activity Of Pax-6, An Important Transcription Factor For Eye And Brain Development

Senp1-Mediated Gata1 Desumoylation is Critical for Definitive Erythropoiesis

SUMO suppresses and MYC amplifies transcription globally by regulating CDK9 sumoylation

SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation

SENP2 Regulates MEF2A De-Sumoylation in an Activity Dependent Manner.

SUMO engages multiple corepressors to regulate chromatin structure and transcription

Differential Regulation of C-Jun Protein Plays an Instrumental Role in Chemoresistance of Cancer Cells

CSN6 Positively Regulates C-Jun in a MEKK1-dependent Manner

Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1)

SUMO functions in constitutive transcription and during activation of inducible genes in yeast

C-Jun As a One-Way Valve at the Naive to Primed Interface.

SENP1 Enhances Androgen Receptor-Dependent Transcription Through Desumoylation of Histone Deacetylase 1

The E3 Ligase APC/C-Cdh1 Regulates MEF2A-dependent Transcription by Targeting SUMO-specific Protease 2 for Ubiquitination and Degradation.

Research progression on biologic function and effect of SUMO-specific proteinase

SENP3 Regulates the Global Protein Turnover and the Sp1 Level Via Antagonizing SUMO2/ 3-Targeted Ubiquitination and Degradation

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

[Sumo-Specific Protease 1 and Cancer].

SUMO modification regulates the transcriptional activity of XBP1.

An Essential Role of Small Ubiquitin-like Modifier (Sumo)-Specific Protease 2 in Myostatin Expression and Myogenesis*

TCR-Induced Tyrosine Phosphorylation at Tyr270 of SUMO Protease SENP1 by Lck Modulates SENP1 Enzyme Activity and Specificity